Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Be nice to c the new sites & patient enrollments

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Mar 26, 2021 4:38pm

203 Views

Post# 32888447

RE:RE:RE:RE:Be nice to c the new sites & patient enrollments

Strictly my opinion, I feel all the adjustments in dosage and light will greatly improved the final CR percentages. I consider ourselves lucky in hindsight for what has occured in the beginning of this Ph2 study and as others have said it has now been fine tuned, my expectations is upward of 80+ . Gut feeling is we've got this one and I'm anxiously waiting for the announcement for GBM & NSCLC.
Yes I also have a good feeling that the single patient treated announcements are a thing of the past and the next announcement will more.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages